PREMIER BIOMEDICAL INC

Profile

Company Names

PREMIER BIOMEDICAL INC

Addresses

1338 SPRINGFIELD CHURCH RD., JACKSON CENTER, PA 16133

1701 DIRECTORS BOULEVARD, AUSTIN, TX 78744

970 LAKE CARILLON DRIVE, SUITE 300, ST. PETERSBURG, FL 33716

10805 FALLEN LEAF LANE, PORT RICHEY, FL 34688

1362 SPRINGFIELD CHURCH ROAD, JACKSON CENTER, PA 16133

Phone Numbers

814-786-8849
814 786 8849

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE, BIOTECHNOLOGY

Year Incorporated:

2010

State Incorporated:

NEVADA

Total Amount Raised:

$2,041,920.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2018-11-23 
$150,000.00 
$150,000.00 
$0.00 
Equity 
6
2015-12-28 
$1,600,000.00 
$1,600,000.00 
$0.00 
Debt 
5
2013-08-22 
$26,500.00 
$26,500.00 
$0.00 
Debt 
4
2012-12-31 
$70,000.00 
$500,000.00 
$430,000.00 
Equity 
3
2012-06-11 
$66,100.00 
$350,000.00 
$283,900.00 
Equity 
2
2011-04-19 
$57,000.00 
$750,000.00 
$693,000.00 
Equity 
1
2011-03-07 
$72,320.00 
$300,000.00 
$227,680.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SCOTT 
 
BARNES 
DIRECTOR
PREMIER BIOMEDICAL INC   |  ARTBANC INTERNATIONAL LTD., INC.   |  FORT GLOBAL DIVERSIFIED LP   |  FORT GLOBAL CONTRARIAN LP   |  FORT VALUE MARKET NEUTRAL, LP   |  FORT GLOBAL FUTURES, L.P.   |  CLASS C SEGREGATED PORTFOLIO OF FORT GLOBAL OFFSHORE, SPC   |  CLASS D SEGREGATED PORTFOLIO OF FORT GLOBAL OFFSHORE, SPC   |  CLASS F SEGREGATED PORTFOLIO OF FORT GLOBAL OFFSHORE, SPC   |  CLASS C SEGREGATED PORTFOLIO OF FORT GLOBAL OFFSHORE FUND, SPC   |  CLASS D SEGREGATED PORTFOLIO OF FORT GLOBAL OFFSHORE FUND, SPC   |  CLASS F SEGREGATED PORTFOLIO OF FORT GLOBAL OFFSHORE FUND, SPC   |  FORT GLOBAL LONG/SHORT, L.P.   |  FORT EQUITY MARKET NEUTRAL, LP   |  SOLITONREACH INC.   |  CAPTURE COLLECTIVE INC.   |  IKOSTRIPS, INC.   |  WASHINGTON HARBOUR CAPITAL LONG ONLY OFFSHORE FUND, LTD.   |  WASHINGTON HARBOUR TELESTO, L.P.   |  WASHINGTON HARBOUR FEDERAL IT, L.P.   |  PERKCITY, INC.   |  ESTIMATE AI SOLUTIONS, LLC
JOHN 
 
BORZA 
DIRECTOR
PREMIER BIOMEDICAL INC
JOHN 
S 
BORZA 
DIRECTOR
PREMIER BIOMEDICAL INC
JOHN 
S. 
BORZA 
DIRECTOR, EXECUTIVE OFFICER
PREMIER BIOMEDICAL INC
HEIDI 
H 
CARL 
EXECUTIVE OFFICER, DIRECTOR
PREMIER BIOMEDICAL INC
HEIDI 
H. 
CARL 
EXECUTIVE OFFICER, DIRECTOR
PREMIER BIOMEDICAL INC
DR. MITCHELL 
S 
FELDER 
DIRECTOR
PREMIER BIOMEDICAL INC
JUSTIN 
 
FELDER 
DIRECTOR
PREMIER BIOMEDICAL INC
JUSTIN 
A 
FELDER 
DIRECTOR
PREMIER BIOMEDICAL INC
MITCHELL 
S 
FELDER 
DIRECTOR, EXECUTIVE OFFICER
PREMIER BIOMEDICAL INC
MITCHELL 
S. 
FELDER 
DIRECTOR, EXECUTIVE OFFICER
PREMIER BIOMEDICAL INC
RAMON 
D 
FOLTZ 
DIRECTOR
PREMIER BIOMEDICAL INC
RAMON 
D. 
FOLTZ 
DIRECTOR
PREMIER BIOMEDICAL INC
WILLIAM 
A 
HARTMAN 
EXECUTIVE OFFICER, DIRECTOR
PREMIER BIOMEDICAL INC
WILLIAM 
A. 
HARTMAN 
DIRECTOR, EXECUTIVE OFFICER
PREMIER BIOMEDICAL INC
RICHARD 
 
NAJARIAN 
DIRECTOR
PREMIER BIOMEDICAL INC
RICHARD 
T 
NAJARIAN 
DIRECTOR
PREMIER BIOMEDICAL INC
RICHARD 
T. 
NAJARIAN 
DIRECTOR
PREMIER BIOMEDICAL INC
JOHN 
C. 
PAULY 
DIRECTOR
PREMIER BIOMEDICAL INC
PATRICIO 
F. 
REYES 
DIRECTOR, EXECUTIVE OFFICER
PREMIER BIOMEDICAL INC
JAY 
 
ROSEN 
DIRECTOR
CRITICAL SIGNAL TECHNOLOGIES INC   |  CONSUMER HEALTH ADVISERS, INC.   |  PREMIER BIOMEDICAL INC   |  HMA CAPITAL PARTNERS II, L.P.   |  GAZETTE CO   |  PUSH WELLNESS SOLUTIONS, INC.
JAY 
WILLIAM 
ROSEN 
DIRECTOR
PREMIER BIOMEDICAL INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-12-03
D
Link
OTHER HEALTH CARE 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2018-11-23 
2015-12-30
D
Link
OTHER HEALTH CARE 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2015-12-28 
2013-08-26
D
Link
OTHER HEALTH CARE 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2013-08-22 
2013-02-27
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2012-12-31 
2013-02-01
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2012-12-31 
2013-01-03
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2012-12-31 
2012-08-09
D/A
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2012-06-11 
2012-06-22
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2012-06-11 
2011-06-08
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2011-04-19 
2011-04-20
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2011-04-19 
2011-03-17
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2011-03-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
CHARDAN CAPITAL MARKETS, LLC
120128